Department of Disease Control reveals the cause of the death of a female teacher from cerebral edema Additional checks are related to vaccination or not.
On July 23, Dr. Chawetsan Namwat, Director of the Emergency Disease and Health Disaster Control Division, Department of Disease Control, Ministry of Public Health (MOPH) reported on surveillance for adverse events after vaccination against COVID-19. that in the event that one female teacher at Prachuap Khiri Khan Province had alternate vaccinations and died 1 day after the second injection.
from reporting the results of the preliminary autopsy The cause of death was Brain swelling from a brain lump causing blood to press on the brain stem I would like to express my condolences to the family of the deceased. for this incident will bring the details together with other evidence to determine whether it is related to vaccination or not. The panel of experts will gather all the evidence and information for consideration, whether it is congenital disease, other health status, into consideration. which will be reported later
Dr. Chawatsan continued that the vaccination part, from the information as of July 22 at 6:00 p.m., Thailand vaccinated a total of 15,388,939 doses, the number of people who received the 1st needle 11,805,180, the 2nd needle, 3,583,759 cases, if separated. The vaccines were classified as follows: Sinovac 7,933,854 doses, Astrazeneca 6,856,472 doses and Sinofarm 598,613 doses. July 18 at 4:30 p.m., the number of vaccines injected 14,298,596 doses, found that AEFI patients meet the criteria for reporting by the Department of Disease Control as follows: 1,343 cases are in force, representing 9.4 per hundred thousand doses of vaccination, 231 deaths, or 1.6 per Hundreds of injections and other patients, such as fever, 2,565, equivalent to 17.9 per 100,000 doses of vaccination, a total of 4,139, or 28.9 per 100,000 doses of vaccination
“The experts have summarized the situation of adverse events after the COVID-19 vaccination. Between February 28 and July 18, people with adverse reactions were found. The cumulative total of 1,592 serious cases was considered by experts, 482 cases were completed. Data is currently under follow-up, 1,110 of the 482 cases, divided into vaccine-related, such as allergic reactions, 71 cases, all cured. Concerning vaccination, there were physical reactions but no abnormalities were detected, 240 cases were treated and all were treated. The co-incidences were not vaccine-related: 36 illnesses, 122 deaths, 13 cases cannot be concluded whether they are vaccine-related or not,” said Dr Chawetsan.
Dr. Chawetsan added that the percentage of symptoms found after receiving the vaccine against COVID-19 of patients admitted as inpatients Classified by type of vaccine received, Sinovac 1,633 cases showed signs and symptoms as follows: dizziness 21.92% headache 15.25% nausea 14.88% vomiting 12.43% fatigue 9.37% myalgia 6.86% rash 6.74% diarrhea 6.00 % unwell 4.41% and fever 3.98% AstraZeneca 1,802 patients had symptoms and signs as follows: fever 24.75% dizziness 21.92% headache 15.25% nausea 14.88% muscle pain 14.21% vomiting 12.43% fatigue 9.37% Diarrhea 9.05%, malaise 8.32%, fainting 3.06% Sinofarm 34 cases Signs and symptoms are as follows: Dizziness 32.35% Nausea 29.41% Vomiting 26.47% Headache 17.65% Itching 8.82% Fatigue 8.82% Fever 8.82% Rash 5.88 % fainting 5.88% and allergic rash 5.88%
Director of the Division of Disease Control added that In this regard, we would like to clarify the issues that people are interested in. A study measuring the efficacy of vaccines administered to healthcare professionals. Of the Chiang Rai Prachanukroh Hospital, divided into 366 fully vaccinated groups (more than 14 days), 24 infected, or 7.1%, and in the 27 unvaccinated group, 11 were infected. accounted for 40.7% found that the group was not vaccinated. The infection was 5.7 times higher than in the vaccinated group.
In conclusion, two doses of the synovac vaccine were 82.5% effective in preventing infection. In addition, four pneumonia cases were found in the one-sine group, representing 1.2%, and the non-vaccinated group had two pneumonia, accounting for 7.4%. non-vaccinated group Pneumonia was 6.2 times higher than the vaccinated group. Summary: Two doses of Sinovac vaccine were 83.9% effective in preventing pneumonia. As for vaccination-19 worldwide, the details are as follows. 3.76 billion doses have been vaccinated worldwide. The world’s population has vaccinated at least one dose, 26.8% has completed 13.4% and currently has about 29.8 million doses vaccinated per day.
